CLEMENTIA PHARMACEUTICALS IN - COM (CMTA)

CUSIP: 185575107

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
20,915,108
Share change
+20,915,108
Total reported value
$353,496,890
Price per share
$16.89
Number of holders
45
Value change
+$353,496,890
Number of buys
45

Quarterly Holders Quick Answers

What is CUSIP 185575107?
CUSIP 185575107 identifies CMTA - CLEMENTIA PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) as of Q3 2017

As of 30 Sep 2017, CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,915,108 shares. The largest 10 holders included ORBIMED ADVISORS LLC, NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, DRIEHAUS CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, RA CAPITAL MANAGEMENT, LLC, FMR LLC, DEERFIELD MANAGEMENT CO, and BlackRock Inc.. This page lists 45 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.